BRIEF published on 04/07/2026 at 07:05, 1 month 8 days ago Aelis Farma obtient une subvention de 458 000 € pour son programme de lutte contre l'obésité France 2030 Aelis Farma Récepteur CB1 Recherche Sur L'obésité Subvention De Nouvelle-Aquitaine
BRIEF published on 04/07/2026 at 07:05, 1 month 8 days ago Aelis Farma Secures €458k Grant for Obesity Program France 2030 Aelis Farma Obesity Research CB1 Receptor Nouvelle-Aquitaine Grant
PRESS RELEASE published on 04/07/2026 at 07:00, 1 month 8 days ago Informations privilégiées / Autres communiqués Aelis Farma reçoit 458 k€ de subvention de France 2030 en Nouvelle-Aquitaine pour son programme innovant dans l'obésité et les maladies métaboliques. Soutien non dilutif pour la recherche sur les traitements des désordres métaboliques Subvention France 2030 Obésité Aelis Farma Nouvelle-Aquitaine
PRESS RELEASE published on 04/07/2026 at 07:00, 1 month 8 days ago Inside Information / Other news releases Aelis Farma receives €458k grant under France 2030 for obesity program development, reinforcing innovation potential in metabolism field Metabolic Diseases Grant France 2030 Obesity Aelis Farma
BRIEF published on 03/21/2026 at 10:10, 1 month 24 days ago Aelis Farma Advances Phase 2B Clinical Trial for Down Syndrome Treatment Clinical Trial CB1 Receptor AEF0217 Down Syndrome Adaptive Behavior
BRIEF published on 03/21/2026 at 10:10, 1 month 24 days ago Aelis Farma fait progresser son essai clinique de phase 2B pour le traitement du syndrome de Down Essai Clinique AEF0217 Syndrome De Down Récepteur CB1 Comportement Adaptatif
PRESS RELEASE published on 03/21/2026 at 10:05, 1 month 24 days ago Informations privilégiées / Autres communiqués Aelis Farma lance avec succès l'étude clinique de Phase 2B avec AEF0217 pour traiter les troubles comportementaux et cognitifs du syndrome de Down. Recrutement actif en France, Italie et Espagne Phase 2b Étude Clinique Aelis Farma AEF0217 Syndrome De Down
PRESS RELEASE published on 03/21/2026 at 10:05, 1 month 24 days ago Inside Information / Other news releases Aelis Farma initiates Phase 2B clinical trial with AEF0217 for Down syndrome cognitive impairments, recruiting in France, Italy, and Spain. A promising first-in-class CB1-SSi inhibitor treatment Phase 2b Aelis Farma AEF0217 Down Syndrome Cognitive Impairments
BRIEF published on 01/12/2026 at 07:35, 4 months 3 days ago Aelis Farma obtient un avis favorable de l'EMA pour AEF0217 dans la trisomie 21 EMA Aelis Farma Trisomie 21 AEF0217 Développement Pédiatrique
BRIEF published on 01/12/2026 at 07:35, 4 months 3 days ago Aelis Farma receives a favorable opinion from the EMA for AEF0217 in trisomy 21 EMA Aelis Farma AEF0217 Down Syndrome Pediatric Development
Published on 05/15/2026 at 09:01, 43 minutes ago Apex Drills 23.1 m of 3.47% REO Within Broader Zone of 137.2 m at 2.01% REO, Extending Mineralization 180 m in Western Step-Out at the Rift Rare Earth Project
Published on 05/15/2026 at 08:00, 1 hour 44 minutes ago Interim Results For The Three Months Ended March 31, 2026
Published on 05/15/2026 at 08:00, 1 hour 44 minutes ago Caledonia Mining Corporation Plc: Non-Executive Director Shareholding Notification
Published on 05/15/2026 at 01:35, 8 hours 9 minutes ago NXT Energy Solutions Announces First Quarter 2026 Results
Published on 05/15/2026 at 01:30, 8 hours 14 minutes ago Nano One Reports Q1 2026 Results and Reminds Shareholders of Upcoming AGM
Published on 05/15/2026 at 09:35, 9 minutes ago H&R GmbH & Co. KGaA publishes Interim Report Q1/2026 and confirms Preliminary Figures
Published on 05/15/2026 at 09:30, 14 minutes ago Nagarro presents Q1 2026 numbers, posts 6.5% YoY revenue growth in constant currency
Published on 05/15/2026 at 09:05, 39 minutes ago Ring-type Blood Pressure Monitor 'CART' Completes UK MHRA Medical Device Approval, Establishing Foundation for Entry into the UK Following Europe
Published on 05/15/2026 at 09:05, 39 minutes ago MediaGo Wins Two Stevie® Awards in the 24th Annual American Business Awards®
Published on 05/15/2026 at 09:00, 44 minutes ago Original-Research: Semperit AG Holding (von NuWays AG): BUY
Published on 05/14/2026 at 09:03, 1 day ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 1 day 15 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 1 day 15 hours ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
